Rain Therapeutics Inc. (RAIN)
Jan 26, 2024 - RAIN was delisted (reason: acquired by Pathos AI)
1.210
-0.020 (-1.63%)
Last trade price
Rain Therapeutics Stock Forecast
RAIN's stock price has decreased by -87.9% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 8 analysts with 12-month price forecasts for Rain Therapeutics stock had an average target of 6.87, with a low estimate of 1.00 and a high estimate of 21.
Analyst Consensus: Buy
* Price targets were last updated on Sep 18, 2023.
Analyst Ratings
The average analyst rating for RAIN stock from 11 stock analysts was "Buy". This means that analysts believed this stock was likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Aug '23 | Sep '23 | Oct '23 | Nov '23 | Dec '23 | Jan '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 8 | 8 | 8 | 8 | 8 | 8 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 11 | 11 | 11 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citigroup | Citigroup | Hold Maintains $1.5 → $1 | Hold | Maintains | $1.5 → $1 | -17.36% | Sep 18, 2023 |
| Mizuho | Mizuho | Strong Buy → Hold Downgrades $17 → $1 | Strong Buy → Hold | Downgrades | $17 → $1 | -17.36% | Jun 5, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Jun 2, 2023 |
| Roth MKM | Roth MKM | Strong Buy → Hold Downgrades $1.2 | Strong Buy → Hold | Downgrades | $1.2 | -0.83% | May 30, 2023 |
| EF Hutton | EF Hutton | Hold Maintains $5 → $2 | Hold | Maintains | $5 → $2 | +65.29% | May 30, 2023 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-1.51
from -2.71
EPS Next Year
-0.46
from -1.51
Revenue Forecast
| Revenue | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|
| High | n/a | n/a | n/a | n/a | n/a | n/a |
| Avg | n/a | n/a | n/a | n/a | n/a | n/a |
| Low | n/a | n/a | n/a | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|
| High | - | - | - | - | - | - |
| Avg | - | - | - | - | - | - |
| Low | - | - | - | - | - | - |
EPS Forecast
| EPS | 2023 | 2024 | 2025 |
|---|---|---|---|
| High | -1.54 | -0.37 | -0.76 |
| Avg | -1.51 | -0.46 | -0.73 |
| Low | -1.46 | -0.55 | -0.71 |
EPS Growth
| EPS Growth | 2023 | 2024 | 2025 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.